Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009771
Filing Date
2025-05-12
Accepted
2025-05-12 17:30:35
Documents
81
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1104703
2 EX-31.1 ex31-1.htm EX-31.1 18573
3 EX-31.2 ex31-2.htm EX-31.2 19056
4 EX-32.1 ex32-1.htm EX-32.1 8152
5 EX-32.2 ex32-2.htm EX-32.2 7863
6 GRAPHIC form10-q_001.jpg GRAPHIC 9098
  Complete submission text file 0001641172-25-009771.txt   7465956

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE scnx-20250331.xsd EX-101.SCH 60569
8 XBRL CALCULATION FILE scnx-20250331_cal.xml EX-101.CAL 86484
9 XBRL DEFINITION FILE scnx-20250331_def.xml EX-101.DEF 313969
10 XBRL LABEL FILE scnx-20250331_lab.xml EX-101.LAB 556064
11 XBRL PRESENTATION FILE scnx-20250331_pre.xml EX-101.PRE 453297
83 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1027442
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39199 | Film No.: 25936223
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)